Acemini structure and related specifications

Asciminib (Asciminib) is a new type of kinase inhibitor mainly used to treat certain types of chronic myelogenous leukemia (CML). Its mechanism of action is through selective inhibition of BCR-ABL kinase, especially against drug-resistant mutants, showing good therapeutic potential. The chemical structure of Aceminib is relatively complex. Its chemical name is N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-pyrrolidin-1-yl]-5-(1H-pyrazol-3-yl)pyridine-3-carboxamide hydrogen chloride (1/1), and its molecular formula is C20H18ClF2N5O3.HCl. The relative molecular weight of acemini hydrochloride is 486.30g/mol, while the relative molecular weight of the free base is 449.84 g/mol.

In the appearance of the drug, acemini hydrochloride appears as a white to slightly yellow powder. This characteristic requires attention during preparation and storage. Depending on the dosage form and usage of the drug, Acemini offers film-coated tablets suitable for oral administration. There are three common specifications: 20mg, 40mg and 100mg of aximini hydrochloride. When using these specifications of drugs, you need to pay attention to their corresponding aximini hydrochloride content, which are 21.62mg, 43.24mg and 108.10mg respectively.

Research on Asiminib shows that Asiminib has significant efficacy in the treatment ofCML, especially in patients who are resistant to traditional targeted therapies such as Imatinib. Clinical trial results show that aceminib can effectively reduce the proliferation of tumor cells and exhibit good inhibitory effects on different mutant BCR-ABL. Its unique structural design makes it more selective in kinase inhibition, thereby reducing the probability of side effects and improving patient tolerance.

In terms of dosage, the use of aximini should follow the guidance of a doctor, and the dosage is usually adjusted based on the patient's specific condition and the progression of the disease. While taking this drug, patients also need to be monitored regularly to evaluate the drug's efficacy and possible side effects.